Form 4: Agilon Health CEO Steven Sell Reports Acquisition and Disposal of Shares
SEC Form 4
CEO Steven Sell reports acquiring and disposing of agilon health, inc. shares, including restricted stock units and options, primarily for tax obligations and vesting purposes.
Summary
- Steven Sell, CEO and President of agilon health, inc., filed a Form 4 detailing changes in beneficial ownership.
- On April 15, 2024, Sell acquired 252,243 shares of common stock through restricted stock units vesting at $0.
- Also on April 15, 2024, Sell acquired 415,130 options with an exercise price of $4.46, vesting in four equal installments annually, starting April 15, 2024.
- On April 14, 2024, 7,875 shares were disposed of to cover income tax withholding obligations at a price of $4.95 per share.
- Following these transactions, Sell directly owns 328,447 shares and indirectly owns 47,590 shares through a trust.
- Sell also directly owns 415,130 derivative securities (options).
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing primarily reflects routine transactions related to stock-based compensation and tax obligations. There's no indication of significant concern or excitement.
Positives
- The acquisition of restricted stock units and options indicates continued alignment of the CEO's interests with the company's performance.
- The vesting schedule of the restricted stock units and options incentivizes long-term commitment from the CEO.
Negatives
- The disposal of shares to cover tax obligations, while routine, slightly reduces the CEO's direct shareholding.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment with company performance.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for publicly traded companies in the US, ensuring transparency in insider trading activities.
- Similar filings are common across the healthcare industry, with executives at companies like UnitedHealth Group (UNH) and Humana (HUM) regularly reporting their transactions.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding the CEO's ownership stake.
- The vesting schedule of the restricted stock units and options aligns the CEO's interests with long-term shareholder value.
Key Dates
| Date | Description |
|---|---|
| 04/14/2024 | Disposal of 7,875 shares for tax obligations. |
| 04/15/2024 | Acquisition of 252,243 shares through restricted stock units and 415,130 options. |
| 04/15/2034 | Expiration date of options acquired on 04/15/2024. |
| 04/17/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.